| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/21/2002 | US20020034506 Method for treatment of tumors using nucleic acid ligands to PDGF |
| 03/21/2002 | US20020034495 Gene therapy |
| 03/21/2002 | DE10136985A1 Für das gap2-Gen kodierende Nukleotidsequenzen For the gap2 gene coding nucleotide sequences |
| 03/21/2002 | DE10132947A1 Für das rodA-Gen kodierte Nukleotidsequenzen For the rodA gene encoded nucleotide sequences |
| 03/21/2002 | DE10132176A1 Neue für das fts-Gen kodierende Nukleotidsequenzen New coding for the fts gene nucleotide sequences |
| 03/21/2002 | DE10112430A1 Neue für das dep33-Gen kodierende Nukleotidsequenzen New coding for the dep33 gene nucleotide sequences |
| 03/21/2002 | DE10112429A1 Neue für das dep34-Gen kodierende Nukleotidsequenzen New coding for the dep34 gene nucleotide sequences |
| 03/21/2002 | DE10109022A1 Neue für das chrS-Gen kodierende Nukleotidsequenzen New coding for the CHRS gene nucleotide sequences |
| 03/21/2002 | DE10044360A1 Verfahren zur Aufreinigung von rekombinanten als unlösliche Aggregate exprimierte Proteinen A process for the purification of recombinant proteins expressed as insoluble aggregates |
| 03/21/2002 | DE10044325A1 Neue MMP-2-Derivate als Inhibitoren des Integrins avbeta3 New MMP-2 derivatives as inhibitors of the integrin avbeta3 |
| 03/21/2002 | DE10033195A1 Bifunktionale Fusionsproteine aus Hirudin und TAP Bifunctional fusion proteins of hirudin and TAP |
| 03/21/2002 | CA2425186A1 Expression, preparation, uses, and sequence of recombinantly-derived soluble hla-g |
| 03/21/2002 | CA2423559A1 22 human secreted proteins |
| 03/21/2002 | CA2422882A1 Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications |
| 03/21/2002 | CA2422814A1 Cripto mutant and uses thereof |
| 03/21/2002 | CA2422497A1 Transporters and ion channels |
| 03/21/2002 | CA2422454A1 Compositions and methods for inducing specific cytolytic t cell responses |
| 03/21/2002 | CA2422426A1 Polymorphic bone morphogenetic protein 2 |
| 03/21/2002 | CA2422293A1 Plant genes, the expression of which are altered by pathogen infection |
| 03/21/2002 | CA2422288A1 Novel mammalian receptor genes and uses |
| 03/21/2002 | CA2422278A1 Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators |
| 03/21/2002 | CA2422275A1 Compositions and methods for inhibition of hiv-1 infection |
| 03/21/2002 | CA2422229A1 Calcium binding proteins |
| 03/21/2002 | CA2422152A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/21/2002 | CA2422080A1 Method to identify therapeutic antibody targets associated with a therapeutic response |
| 03/21/2002 | CA2422068A1 Method for treatment of insulin resistance in obesity and diabetes |
| 03/21/2002 | CA2422060A1 Compositions comprising mixtures of human cytokines and methods of producing the same |
| 03/21/2002 | CA2422053A1 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses tehreof |
| 03/21/2002 | CA2422041A1 Antimicrobial peptides and methods of use |
| 03/21/2002 | CA2422033A1 Method for treating inflammation |
| 03/21/2002 | CA2421952A1 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof |
| 03/21/2002 | CA2421949A1 Novel nucleic acids and polypeptides |
| 03/21/2002 | CA2421786A1 Compounds and methods for inhibiting alpha-1 beta-1 integrins |
| 03/21/2002 | CA2421751A1 Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom |
| 03/21/2002 | CA2421747A1 Polymorphisms associated with cardiac arrythmia |
| 03/21/2002 | CA2421303A1 Novel compounds |
| 03/21/2002 | CA2421234A1 Interferon-alpha induced gene |
| 03/21/2002 | CA2420932A1 Novel mammalian nuclear receptor l66 and methods of use |
| 03/21/2002 | CA2420892A1 Human coagulation factor vii variants |
| 03/21/2002 | CA2420705A1 17 human secreted proteins |
| 03/21/2002 | CA2420504A1 Muteins of the cgrp 1-7 peptide fragment and use thereof as nicotinic neuronal receptor enhancers |
| 03/21/2002 | CA2420459A1 Novel dermatophagoides nucleic acid molecules, proteins and uses thereof |
| 03/21/2002 | CA2419894A1 Process for high throughput screening of cpg-based immuno-agonist/antagonist |
| 03/21/2002 | CA2391407A1 Antigenic proteins of shrimp white spot syndrome virus and uses thereof |
| 03/20/2002 | EP1189063A1 Method for detecting PSA and its molecular forms using thiophilic gel |
| 03/20/2002 | EP1188834A1 Recombinant MVA expressing the HER-2/neu gene |
| 03/20/2002 | EP1188832A1 A delivery method for the tumor specific apoptosis inducing activity of apoptin |
| 03/20/2002 | EP1188831A2 Target of RNAIII activating protein (TRAP) |
| 03/20/2002 | EP1188830A1 Novel hemopoietin receptor protein nr10 |
| 03/20/2002 | EP1188828A1 Reg-binding protein |
| 03/20/2002 | EP1188824A2 Human foam cells and methods for preparing them, monoclonal antibodies to said foam cells and their pharmaceutical and diagnostic use |
| 03/20/2002 | EP1188770A1 Substance binding to the substrate of activated blood coagulation factor in competition with this factorto thereby regulate the r eaction between the activated blood coagulation factor and the substrate, a process for producing the substance and blood coagulation factor-adsorbent with the use of the |
| 03/20/2002 | EP1188769A2 High resolution crystal structure of the ribosome and design of protein synthesis inhibitors |
| 03/20/2002 | EP1188767A1 Isolated antioxidant peptides from casein and methods for preparing, isolating and identifying antioxidant peptides |
| 03/20/2002 | EP1188766A1 Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 03/20/2002 | EP1188448A2 Heparin-binding growth factors for gene therapy and anterior eye disorders |
| 03/20/2002 | EP1188444A1 FSH and FSH variant formulations, products and methods |
| 03/20/2002 | EP1187938A1 Method of transposon-mediated mutagenesis in the nematode caenorhabditis elegans |
| 03/20/2002 | EP1187932A2 Mammalian toll homologues and uses thereof |
| 03/20/2002 | EP1187931A1 49 human secreted proteins |
| 03/20/2002 | EP1187927A2 Hcv/bvdv chimeric genomes and uses thereof |
| 03/20/2002 | EP1187925A1 Pectate lyase fusion for expression and secretion of polypeptides |
| 03/20/2002 | EP1187923A1 Apoptosis inhibition by adenovirus e3/6.7k |
| 03/20/2002 | EP1187922A2 Pesticidal proteins |
| 03/20/2002 | EP1187921A1 Compositions affecting programmed cell death and their use in the modification of forestry plant development |
| 03/20/2002 | EP1187920A2 Recombinant prion-like genes and proteins and materials and methods comprising same |
| 03/20/2002 | EP1187918A1 Tek antagonists |
| 03/20/2002 | EP1187917A1 Cd44 splice variant associated with rheumatoid arthritis |
| 03/20/2002 | EP1187916A2 Identification and molecular characterisation of proteins, expressed in the tick salivary glands |
| 03/20/2002 | EP1187915A2 Compounds for therapy and diagnosis of lung cancer and methods for their use |
| 03/20/2002 | EP1187914A1 A structured peptide scaffold for displaying turn libraries on phages |
| 03/20/2002 | EP1187912A1 In vivo insect model system for type-2 diabetes |
| 03/20/2002 | EP1187910A1 Methods for enhancing plant defense |
| 03/20/2002 | EP1187908A1 42 human secreted proteins |
| 03/20/2002 | EP1187852A1 EXPRESSION AND EXPORT OF INTERFERON-ALPHA PROTEINS AS Fc FUSION PROTEINS |
| 03/20/2002 | EP1187851A1 Novel integrin alpha subunit and uses thereof |
| 03/20/2002 | EP1187850A1 Antimicrobial theta defensins and methods of using same |
| 03/20/2002 | EP1187849A1 Meth1 and meth2 polynucleotides and polypeptides |
| 03/20/2002 | EP1187848A1 Annexin derivatives with endogenous chelation sites |
| 03/20/2002 | EP1187845A2 Tumor suppressor molecules and methods of use |
| 03/20/2002 | EP1187843A1 Angiogenic proteins and uses thereof |
| 03/20/2002 | EP1187842A1 Human tumor necrosis factor receptor tr10 |
| 03/20/2002 | EP1187841A1 Method for enhanced protein stabilization and production of cell lines useful for production of such stabilized proteins |
| 03/20/2002 | EP1187627A2 Uses of h-trek-1 polypeptides and polynucleotides encoding them |
| 03/20/2002 | EP1187626A1 Methods for producing 5'-nucleic acid-protein conjugates |
| 03/20/2002 | EP1187625A1 Structure-based design of compounds that inhibit detrimental cytotoxic t lymphocyte responses |
| 03/20/2002 | EP1187624A1 Conformationally constrained backbone cyclized interleukin-6 antagonists |
| 03/20/2002 | EP1187591A2 Ibd-associated microbial antigens and methods of using same |
| 03/20/2002 | EP1035860A4 Non-toxic immune stimulating enterotoxin compositions |
| 03/20/2002 | EP0948340B1 Biologically active substances, method for obtaining and compositions containing them |
| 03/20/2002 | EP0733212B1 A diagnostic antigen and a method of in vitro diagnosing an active infection caused by hepatitis c virus |
| 03/20/2002 | EP0672421B1 Endothelin activity inhibitor |
| 03/20/2002 | EP0625043B1 Recombinant multivalent m protein vaccine |
| 03/20/2002 | EP0610475B1 Nerve-derived transglutaminase enzyme useful for inducing nerve regeneration |
| 03/20/2002 | EP0593501B1 Biocidal proteins |
| 03/20/2002 | EP0589961B1 Assay systems for neurotrophin activity |
| 03/20/2002 | EP0418316B1 Platelet-specific chimeric immunoglobulin |
| 03/20/2002 | CN1341151A Herbicide target gene and methods |
| 03/20/2002 | CN1341150A 疟疾疫苗 Malaria Vaccine |
| 03/20/2002 | CN1341146A Fungal cells with inactivated DNA mismatch repair system |